Abiopharma

🔍 Mountcastle David (Executive)

Company: Privia Health Group, Inc. (PRVA)

Report Date: 2026-03-10

Detailed Transactions and Holdings:

• Acquired 35,335 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-03-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 197,238.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 42,584 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-03-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 239,822.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-03-10 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 8,695.00

Footnotes:

• F1: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.
• F2: Vesting and distribution to reporting person of 42,584 shares underlying performance stock units that were granted on May 9, 2023 for the performance period 2023-2025 .